Nutex Health Inc.
NUTX
$90.28
-$15.06-14.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 82.36% | 236.03% | 187.10% | 141.25% | 93.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.36% | 236.03% | 187.10% | 141.25% | 93.80% |
| Cost of Revenue | 55.90% | 101.77% | 75.40% | 46.52% | 32.69% |
| Gross Profit | 113.42% | 556.44% | 508.61% | 470.13% | 321.71% |
| SG&A Expenses | -9.24% | 362.92% | 378.80% | 160.66% | 77.67% |
| Depreciation & Amortization | 8.21% | 12.25% | 13.48% | 11.78% | 7.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.05% | 135.32% | 113.53% | 60.11% | 37.45% |
| Operating Income | 184.96% | 1,201.39% | 1,327.75% | 4,847.09% | 10,768.45% |
| Income Before Tax | 122.88% | 1,208.89% | 731.67% | 544.00% | 326.49% |
| Income Tax Expenses | 328.89% | 2,139.76% | 2,129.02% | 1,030.33% | 396.44% |
| Earnings from Continuing Operations | 90.24% | 912.30% | 635.11% | 494.55% | 318.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -156.55% | -1,535.25% | -1,167.61% | -1,730.39% | -1,707.48% |
| Net Income | 35.88% | 393.11% | 248.72% | 279.69% | 213.78% |
| EBIT | 184.96% | 1,201.39% | 1,327.75% | 4,847.09% | 10,768.45% |
| EBITDA | 163.57% | 725.98% | 643.68% | 968.43% | 861.69% |
| EPS Basic | 7.98% | 322.78% | 222.29% | 243.04% | 192.66% |
| Normalized Basic EPS | 187.69% | 1,260.93% | 473.54% | 446.92% | 285.87% |
| EPS Diluted | 1.10% | 305.44% | 209.90% | 231.56% | 187.71% |
| Normalized Diluted EPS | 191.90% | 1,139.65% | 413.06% | 416.14% | 274.88% |
| Average Basic Shares Outstanding | 26.33% | 23.23% | 19.01% | 17.22% | 15.94% |
| Average Diluted Shares Outstanding | 31.64% | 32.85% | 26.39% | 24.85% | 17.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 10.27% | 6.22% | 11.29% | 3.51% | 1.16% |